What did @owen.lifts8 actually say?
Owen is 17, has been self-administering what he calls "HCH" (almost certainly HGH, human growth hormone) and GHK-Cu for two months, and is hiding both the peptides and the syringes from his parents in a mini fridge under his bed. He reports gaining two centimeters in height, improved sleep, faster hair growth, and some muscle gains. He offers to DM followers his peptide source, syringe specs, and dosing details. He mentions injecting "about eight" units of HGH daily and considers bumping his GHK-Cu from 2.5-5 mg up to 7 mg. He also openly wonders whether his growth plates are still open.
That last detail is not a throwaway line. It is the most medically significant thing he said, and he treated it like a footnote.
Does the science back this up?
Some of the individual effects he describes are plausible in adults. None of this has been studied in healthy 17-year-olds using unregulated, self-sourced peptides with no physician oversight. The risk-to-evidence ratio here is genuinely bad.
HGH does improve sleep architecture in GH-deficient adults. Takahashi et al. (1968, Science) established the link between GH secretion and slow-wave sleep decades ago, and later work confirmed exogenous GH can deepen sleep in deficient populations. But Owen is 17, almost certainly not GH-deficient, and his own pituitary is still producing GH at near-peak adolescent levels. Adding exogenous HGH on top of that is not optimization, it is interference.
GHK-Cu has real preclinical data behind it. Pickart and Margolina (2018, Biomedicines) reviewed evidence for GHK-Cu's role in skin remodeling and wound healing, but the human clinical trial base is thin and most dosing data comes from topical applications, not subcutaneous injection. Accelerated hair growth at a follicular level is biologically plausible, but "I need a haircut every three weeks now" is not a controlled observation.
The two-centimeter height claim is the weakest. Normal adolescent growth at 17 can be 1-2 cm over two months without any intervention, particularly in late-pubescent males.
What did they get wrong (or right)?
Let's be direct about what's wrong here. Administering exogenous HGH to a non-deficient adolescent carries documented risks including glucose dysregulation, potential premature growth plate closure (the opposite of what he wants), and long-term pituitary suppression. The Endocrine Society's clinical practice guidelines (Grimberg et al., 2016, JCEM) are unambiguous: HGH therapy in pediatric patients is indicated only for confirmed GH deficiency or specific approved conditions, monitored by a physician with IGF-1 testing and bone age imaging.
He is doing none of that. He does not know his IGF-1 levels. He has no bone age X-ray. He has no physician. He is sourcing from a DM-only supplier.
What he got approximately right: GHK-Cu at subcutaneous doses does have some evidence for skin and hair effects. His observation that results were modest is actually more honest than most peptide influencers. Credit for that.
What is dangerous beyond the pharmacology: he is actively coaching minors to replicate this, offering to share his source and syringe details via DM. That is not a health journey update. That is recruitment.
What should you actually know?
If you are under 18, no legitimate prescribing physician will put you on HGH unless you have a confirmed, diagnosed deficiency with documented growth failure. That is not gatekeeping, that is the protocol existing because unsupervised GH use in adolescents has real consequences for adult endocrine function.
Research-grade peptides sold through DM-only sources have no quality assurance. A 2018 study by Rasmussen et al. (JAMA Internal Medicine) found that a substantial portion of compounded peptides from unregulated sources failed purity and concentration standards. You genuinely do not know what is in the vial.
The "best sleep ever" effect Owen describes is real enough that it should concern you, not reassure you. Exogenous GH suppresses endogenous GH release through negative feedback on the hypothalamus. At 17, when your natural GH pulse amplitude is at its lifetime peak, suppressing that system is a significant trade-off for a subjective sleep improvement.
If a 17-year-old is genuinely concerned about growth, recovery, or skin health, those conversations belong in a doctor's office with blood work, not in a TikTok DM with a peptide supplier.